[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342819-105":3,"doc-detail-342819-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","baseline-characteristics-and-recruitment-for-swog-s1820-altering-intake-managing-bowel-symptoms-in-survivors-of-rectal-cancer-aims-rc","Baseline characteristics and recruitment for SWOG S1820 - altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC)","","Study recruitment and pre-randomization baseline characteristics are presented for SWOG S1820, a trial evaluating the Altering Intake, Managing Symptoms in Rectal Cancer (AIMS-RC) intervention. The study addresses persistent bowel dysfunction after rectal cancer, where evidence-based symptom management remains limited. Eligibility included adults more than 18 years old, 6–24 months post primary treatment, with an ostomy or anastomosis. Outcomes cover bowel function, low anterior resection syndrome, quality of life, motivation, self-efficacy, affect, and feasibility/acceptability.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/baseline-characteristics-and-recruitment-for-swog-s1820-altering-intake-managing-bowel-symptoms-in-survivors-of-rectal-cancer-aims-rc/342819/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/baseline-characteristics-and-recruitment-for-swog-s1820-altering-intake-managing-bowel-symptoms-in-survivors-of-rectal-cancer-aims-rc/342819.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the purpose of SWOG S1820?","Question",{"text":63,"@type":64},"SWOG S1820 aimed to describe recruitment and pre-randomization baseline sociodemographic, health, and clinical characteristics for an intervention targeting persistent bowel dysfunction in rectal cancer survivors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What participants were eligible for SWOG S1820?",{"text":68,"@type":64},"Eligible survivors were adults (over 18 years) with rectosigmoid colon or rectum cancer history, enrolled 6–24 months after completing primary treatment, and having a permanent ostomy or anastomosis.",{"name":70,"@type":61,"acceptedAnswer":71},"What recruitment results were reported at baseline?",{"text":72,"@type":64},"The trial completed accrual over 29 months and enrolled 117 participants from 34 institutions across 17 states and one US Pacific territory, with many reporting self-imposed diet changes and persistent constipation and diarrhea.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342819,1790583793,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819",8,"Supportive Care in Cancer (2024) 32:371  \n[https://doi.org/10.1007/s00520-024-08527-x](https://doi.org/10.1007/s00520-024-08527-x)  \nBaseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS‑RC)  \nVirginia Sun1 · Cynthia A. Thomson2 · Tracy E. Crane3 · Kathryn B. Arnold4 · Katherine A. Guthrie4 ·  \nSarah G. Freylersythe3 · Christa Braun‑Inglis5 · Lee Jones6 · Joseph C. Carmichael7 · Craig Messick8 · Devin Flaherty9 · Samir Ambrale5,10 · Stacey A. Cohen11 · Robert S. Krouse12  \nReceived: 19 October 2023 / Accepted: 27 April 2024 / Published online: 22 May 2024 © The Author(s) 2024  \nAbstract  \nPurpose Many survivors of rectal cancer experience persistent bowel dysfunction. There are few evidence-based symptom management interventions to improve bowel control. The purpose of this study is to describe recruitment and pre-randomization baseline sociodemographic, health status, and clinical characteristics for SWOG S1820, a trial of the Altering Intake, Managing Symptoms in Rectal Cancer (AIMS-RC) intervention.  \nMethods SWOG S1820 aimed to determine the preliminary efficacy, feasibility, and acceptability of AIMS-RC, a symptom management intervention for bowel health, comparing intervention to attention control. Survivors with a history of cancers of the rectosigmoid colon or rectum, within 6–24 months of primary treatment completion, with a post-surgical permanent ostomy or anastomosis, and over 18 years of age were enrolled. Outcomes included total bowel function, low anterior resection syndrome, quality of life, motivation for managing bowel health, self-efficacy for managing symptoms, positive and negative affect, and study feasibility and acceptability.  \nResults The trial completed accrual over a 29-month period and enrolled 117 participants from 34 institutions across 17 states and one US Pacific territory. At baseline, most enrolled participants reported self-imposed diet adjustments after surgery, persistent dietary intolerances, and bowel discomfort post-treatment, with high levels of constipation and diarrhea (grades 1–4) . Conclusions SWOG S1820 was able to recruit, in a timely manner, a study cohort that is demographically representative of US survivors of rectal cancer. Baseline characteristics illustrate the connection between diet/eating and bowel symptoms posttreatment, with many participants reporting diet adjustments and persistent inability to be comfortable with dietary intake. [ClinicalTrials.gov](ClinicalTrials.gov) registration date 12/19/2019 .  \n[ClinicalTrials.gov](ClinicalTrials.gov) Identifier NCT\\#04205955 .  \nKeywords Quality of life · Bowel dysfunction · Intervention · Self-management · Diet modification  \n* Virginia Sun [vsun@coh.org](vsun@coh.org)  \n1 Department of Population Sciences and Department of Surgery, City of Hope, Duarte, CA 91010, USA  \n2 University of Arizona Cancer Center, Tucson, AZ, USA  \n3 Division of Medical Oncology, Miller School of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA  \n4 SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA, USA  \n5 University of Hawaii Cancer Center, Honolulu, HI, USA  \n6 Research Advocate, Arlington, VA, USA  \n7 Division of Colon & Rectal Surgery, Department of Surgery, University of California Irvine, Irvine, CA, USA  \n8 Department of Colon and Rectum Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA  \n9 ValleyHealth/Winchester Medical Center, Winchester, VA, USA  \n10 FHP Health Center, Guam, USA  \n11 University of Washington and Fred Hutchinson Cancer Center, Seattle, WA, USA  \n12 Perelman School of Medicine, University of Pennsylvania and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA  \nIntroduction  \nIn the USA, there are over 1.4 million people living with a history of colorectal cancer, with a rapid shift of ri","cbCaifzrxftj1S7g","https://ap.wps.com/l/cbCaifzrxftj1S7g","pdf",812811,11,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the purpose of SWOG S1820?\",\"answer\":\"SWOG S1820 aimed to describe recruitment and pre-randomization baseline sociodemographic, health, and clinical characteristics for an intervention targeting persistent bowel dysfunction in rectal cancer survivors.\"},{\"question\":\"What participants were eligible for SWOG S1820?\",\"answer\":\"Eligible survivors were adults (over 18 years) with rectosigmoid colon or rectum cancer history, enrolled 6–24 months after completing primary treatment, and having a permanent ostomy or anastomosis.\"},{\"question\":\"What recruitment results were reported at baseline?\",\"answer\":\"The trial completed accrual over 29 months and enrolled 117 participants from 34 institutions across 17 states and one US Pacific territory, with many reporting self-imposed diet changes and persistent constipation and diarrhea.\"}]","Baseline characteristics and recruitment for SWOG S1820 - altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC) | PDF",1790048311,28,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53135cfc999d0c07a130650561aa22e0.webp",983,1305,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6466be1673ac51155cb942e8ed58dfb5.webp",982,1304,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/839be94809b0235efe7b7801bdc6a3d3.webp",981,1303,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e15f5e1bcb78c8fc9123613e0eb91d6.webp",980,1301,{"code":4,"msg":82,"data":117},[118,122,126,130,135,139,144,147,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":145,"slug":146},30,"research-report",{"id":148,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},9,"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]